IPO Government Approvals India 2026: DRHP Licence, Renewal & Due Diligence Checklist

IPO government approvals in India are not a last-minute legal annex. For a company preparing a DRHP, the approvals schedule is a practical readiness test: identify every material licence, registration, consent and permit required for the present business, verify validity and renewal status, reconcile gaps with risk-factor disclosure, and create evidence that can survive merchant-banker, legal and financial due diligence.

IPO Government Approvals India: what the DRHP needs to establish

Recent SEBI-filed offer documents commonly contain a dedicated “Government and Other Approvals” section. The exact approvals are business-specific. Manufacturing issuers may need factory, pollution-control, fire, explosives, electricity or sector registrations; financial-services issuers may depend on RBI, IRDAI or other regulated permissions; exporters may have DGFT or export-promotion registrations. The objective is not to create the longest possible licence list. It is to identify approvals that are material and necessary for the issuer’s current business and disclose their status accurately.

A September 2025 SEBI-filed RHP, for example, describes its schedule as an indicative list of approvals, licences, registrations and permits considered material and necessary for business activities and links approval risk to the risk-factor section. Another SEBI-filed document expressly separates approvals obtained, renewal applications pending, applications yet to be made, and approvals required but not obtained or applied for. That distinction is useful for IPO readiness because “we have a licence register” is not the same as “every material approval is current and evidenced.”

1. Build an approval universe before deciding materiality

Start with the operating footprint, not with last year’s compliance spreadsheet. Map each plant, office, warehouse, branch, product line, regulated activity, import/export activity and material subsidiary. For each location or activity, identify the licence, issuing authority, legal entity named on the approval, issue date, expiry date, renewal window, conditions, amendments and supporting evidence.

The register should also distinguish company-level approvals from site-level approvals. A registration held by the parent does not automatically cover a subsidiary, and an approval for one factory does not automatically cover a second facility. Changes in company name, registered office, capacity, product mix or ownership can also create amendment requirements.

2. Classify every approval by IPO readiness status

A practical pre-DRHP status matrix can use five buckets: valid and evidenced; renewal filed and pending; expiring before the expected offer timetable; required but application not yet filed; and potentially applicable but under legal review. Add an owner and target remediation date to every open item.

This turns the exercise from disclosure drafting into project management. The CFO and company secretary can immediately see which gaps may affect the timetable, which require legal interpretation, and which need operational action rather than drafting language.

3. Reconcile approvals with risk factors and the business chapter

The approvals section cannot be reviewed in isolation. If the business chapter says a facility performs a regulated activity, the approval matrix should explain the legal permissions supporting it. If a licence has expired, renewal is pending or a material approval is absent, the risk-factor analysis should be consistent with that fact. Contradictions between the licence register, business description, legal diligence report and DRHP are avoidable review issues.

Worked example: pre-IPO approvals cleanup

Illustrative case only: assume an industrial company operates three plants and management initially provides a register containing 74 licences. Due diligence finds that 58 are current, eight have timely renewal applications, four will expire within six months, two are recorded under an old company name, one site has expanded capacity without the corresponding amendment being evidenced, and one permit is still being assessed for applicability.

The correct response is not to label all 74 items “compliant.” The IPO workstream should obtain renewal acknowledgements, determine whether operations can legally continue while renewals are pending, file or document amendments, obtain legal conclusions on uncertain applicability, and ensure that material unresolved items are reflected consistently in the offer-document disclosure. This is where a well-run data room materially reduces drafting cycles.

4. Check expiry dates against the IPO timetable

An approval valid on the first diligence date can expire before the RHP or listing. Build a forward-looking expiry calendar covering the expected DRHP, updated DRHP where relevant, RHP and listing timetable. High-risk renewals should be escalated early, particularly where the regulator has discretion, physical inspection is required, or a lapse could interrupt operations.

5. Test licence conditions, not only the certificate

A valid-looking certificate does not prove compliance with its conditions. Diligence should test material operating conditions such as approved capacity, premises, products, environmental parameters, reporting requirements, security deposits, periodic filings and display or record-keeping obligations where applicable. The legal team should determine the consequence of non-compliance; finance teams should identify any related provision, penalty, contingent liability or capex requirement.

6. Link approvals to financial and operational diligence

Approval gaps can have financial consequences. A capacity restriction may affect forecast assumptions. Environmental remediation may require capex. A licence dispute may create a contingent liability. A pending sector approval can affect a proposed object of the issue or expansion plan. These connections are why IPO readiness should combine legal, financial and operational diligence instead of maintaining separate unconnected checklists.

CFO / promoter pre-DRHP checklist

Before the approvals section is frozen, confirm: all operating locations and material subsidiaries are mapped; materiality has been reviewed with counsel; copies and renewal acknowledgements are in the data room; entity names and addresses match current corporate records; expiry dates are tracked through the IPO timetable; conditions and amendments have been tested; unresolved gaps are escalated; risk factors are consistent; financial consequences are assessed; and the final schedule ties back to the legal diligence report.

Common red flags

Common problems include relying on an old licence register, treating a renewal application as equivalent to a renewed approval, missing site-specific permits, licences in a predecessor or promoter name, unrecorded changes in capacity, inconsistent expiry dates, missing subsidiary approvals, and describing a gap differently across the DRHP, legal diligence report and management responses.

How this fits into the wider IPO readiness cluster

Approvals work should run alongside the PGT IPO Readiness Checklist, not after the financial work is complete.

Maintain supporting documents in the IPO Data Room Checklist and reconcile approval-related exposures with the legal and finance workstreams.

Where a gap creates a possible claim, penalty or financial exposure, cross-check it against IPO Litigation Disclosure and the restated financial information.

FAQs

Are all licences required to be listed in an IPO offer document?

The disclosure exercise is driven by the applicable framework and materiality, and the mix is issuer-specific. Recent offer documents describe material approvals necessary for present business activities rather than treating every routine certificate as equally significant. Counsel and the lead managers should determine the appropriate disclosure for the issuer.

What if an approval renewal is pending?

Do not hide the status. Maintain evidence of the renewal application, determine the legal position during the pending period, assess operational and financial consequences, and ensure the DRHP and risk-factor disclosure are consistent where the matter is material.

Should finance teams be involved in government-approval diligence?

Yes. Legal advisers determine legal requirements and consequences, but finance teams should quantify potential penalties, capex, shutdown exposure, contingent liabilities and forecast effects. This is particularly important where an approval affects capacity, a proposed expansion or an object of the issue.

Practical takeaway

For IPO readiness, the strongest approvals file is not simply a folder of certificates. It is a controlled register that proves what the business requires, what it currently holds, what is expiring or pending, what conditions matter, and how unresolved issues connect to risk factors, financial statements and the offer narrative. PGT & Associates can support promoters and finance teams with IPO-readiness financial diligence, data-room organization and reconciliation of approval-related financial exposures, working alongside the issuer’s legal counsel and SEBI-registered intermediaries. No listing, regulatory or financing outcome is guaranteed.

Official filing references

SEBI-filed Government and Other Approvals example: September 2025 RHP.

SEBI-filed approvals status example: July 2025 DRHP.

Recent 2026 filing showing licence/approval risk linked to the Government and Other Approvals section: March 2026 DRHP.